Practical Application of Immuno-Oncology in Renal Cell Carcinoma

In this online program based on a dynamic CCO symposium from the 2020 ASCO GU symposium, experts discuss the use of immunotherapy in treating patients with RCC. Use the updated irAE decision support tool and download the slides now.
Brian A. Costello, MD
M. Dror Michaelson, MD, PhD
Elizabeth R. Plimack, MD, MS
Martin H. Voss, MD

Downloadable Slidesets

Download this slideset from M. Dror Michaelson, MD, PhD, on his perspective for the optimal use of systemic therapy in the first-line setting for favorable-risk patients with advanced RCC.

Brian A. Costello, MD M. Dror Michaelson, MD, PhD Released: February 13, 2020

Download this slideset from Martin H. Voss, MD, to learn more about selecting optimal first-line therapy for intermediate-risk/poor-risk patients with advanced RCC.

Martin H. Voss, MD Released: February 13, 2020

Download this slideset from Elizabeth R. Plimack, MD, MS, to see the latest data on treatment options for advanced RCC after previous therapy as well as how to manage AEs associated with RCC therapy.

Elizabeth R. Plimack, MD, MS Released: February 13, 2020

Interactive Decision Support Tool

Use this mobile-friendly interactive algorithm tool to receive National Comprehensive Cancer Network® (NCCN®) guidance on optimal management of immune-related adverse events associated with immune checkpoint inhibitor therapy, adapted from the NCCN Guidelines for Management of Immunotherapy-Related Toxicities v1.2020.

Released: April 21, 2020
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Pfizer and EMD Serono

Supported by a medical education grant from
Exelixis, Inc.
Supported by an independent educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?